Cancer Insurance Policies
August 12th, 2010
Denial or Underpayment of Benefits under Cancer Insurance Policies
Insurance companies are in business to make a profit. Not paying a claim, delaying a claim payment, or offering an inadequate settlement all help to increase their profits at the expense of their policyholders. At Pendley, Baudin & Coffin, L.L.P., we help our clients receive the benefits they need and are entitled to receive under their cancer insurance policies.
We are here to help you.
Click here or call 225-687-6396 or 1-888-725-2477 to contact us today. No fee unless we collect for you.
Cancer insurance policyholders who have been paid benefits under a supplemental cancer insurance policy may be entitled to additional compensation.
Pendley, Baudin & Coffin, L.L.P., is investigating the possibility that supplemental cancer insurance company policyholders may have only been paid a small portion of the benefits to which they are entitled from supplemental cancer insurance companies under their supplemental cancer insurance policies.
Some supplemental cancer insurance policyholders were guaranteed, under their cancer insurance policies, that they would receive benefits based on the “actual charges” that appeared on their medical bills for their cancer treatment. Despite this guarantee, some supplemental cancer insurance companies changed their adjusting practices without policyholder consent or knowledge and began to pay benefits based on the discounted payments of medical expenses paid by other major medical insurances, including Blue Cross and Medicare.
As an example, pursuant to the previous adjusting practice, if the doctor billed $1,000 for cancer treatment, the cancer insurance companies would pay $1,000 cash to the cancer policyholder, regardless if the doctor accepted less for his services from the cancer policyholder’s other major medical insurance carriers, including Blue Cross and Medicare.
Under the new adjusting practice, if the doctor billed $1,000 for cancer treatment, and later accepted $500 as full payment from Blue Cross or Medicare, the supplemental cancer insurance company would only pay $500 cash to the cancer policyholder. With this example, you can easily see that the change in adjusting practice greatly benefits the cancer insurance company, and not the cancer policyholder.
Our firm is currently representing individuals that received the lower benefits and have alleged that the supplemental cancer insurance companies have breached their insurance contracts with their cancer insurance policyholders by paying the lower benefits. Some of the companies that may be involved in this practice are Life of Alabama Insurance Company and Philadelphia American Life Insurance Company.
Our law firm is also investigating the possibility that supplemental cancer insurance company policyholders have been denied cancer treatment benefits because the cancer insurance company takes a very narrow view of what comprises cancer treatment, or the company relies on ambiguous policy language and exclusions to deny benefits. Our law firm is currently representing cancer policyholders who have been denied significant cash benefits by their cancer insurance companies for these very reasons.
Our firm is also representing individuals whose claims were adjusted downward based on what the insurance company deemed to be the “reasonable and customary” charges for the services received. Our investigation has revealed that these companies use third party databases to determine “reasonable and customary” charges and that the databases may be skewed to benefit the company at the expense of its insureds.
If you or a loved one has suffered from financial hardship when your claim for supplemental cancer insurance benefits was denied, you may qualify for damages or remedies.
Call Pendley, Baudin & Coffin, L.L.P. 225-687-6396 or 1-888-725-2477. Free confidential initial consultation.This entry was posted in Current Cases, firm-news. Bookmark the permalink.
Comments are closed.